YOSHIO YAMAOKA to Bismuth
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Bismuth.
Connection Strength
0.409
-
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori-Infected Peptic Ulcer Children in Vietnam. Helicobacter. 2024 Nov-Dec; 29(6):e13149.
Score: 0.217
-
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions. Gut. 2025 Sep 08; 74(10):1561-1570.
Score: 0.058
-
Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial). Sci Rep. 2024 04 18; 14(1):8986.
Score: 0.052
-
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. Am J Gastroenterol. 2023 07 01; 118(7):1184-1195.
Score: 0.048
-
Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
Score: 0.034